A systematic review and meta-analysis involving 2,338 participants found that arterial compression hemostasis devices significantly reduced compression hemostasis time by 13.9 minutes and limb immobilization time by 8.79 minutes compared to traditional methods. Additionally, these devices lowered the rates of local bleeding, hematoma formation, skin ecchymosis, and other vascular complications. The findings support the superiority of arterial compression devices in improving safety and efficiency during interventional treatments for hepatocellular carcinoma.
Review by Liu H, Yang L, Qin Q and Cui L in World J Surg Oncol
© 2024. The Author(s).